Securities and Exchange Commission
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
NOVEMBER 30, 2012
MESA LABORATORIES, INC.
Commission File Number: 0-11740
Issuers telephone number, including area code: (303) 987-8000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS
Mesa Laboratories, Inc. (the Company) announced the retirement of its Vice President and Chief Financial Officer, Steven W. Peterson, effective as of the close of business on November 30, 2012. In addition, the Company announced that its Board of Directors has appointed John V. Sakys as its Chief Financial Officer and Corporate Secretary. For additional details, see the Companys Current Report on Form 8-K dated October 8, 2012.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.